Last Update

2005-04-15T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Ulrich Bartke?

Mr. Ulrich Bartke

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Vice President, Global Sales and Marketing

Inyx , Inc.

Self-Employed Consultant

Inyx , Inc.

Vice President Global Sales and Marketing

PowderJect Pharmaceuticals Plc

Different Executive Capacities

GlaxoSmithKline plc

Number of Different Executive Capacities

GlaxoSmithKline plc

Education

Ph.D.

Pharmaceutical Chemistry

University of Berlin

BSc

Pharmacy

University of Berlin

Web References (3 Total References)


SEC EDGAR Submission 0000950134-05-007535

www.sec.gov [cached]

Ulrich Bartke

...
Ulrich Bartke - Vice President, Global Sales and Marketing.Mr. Bartke joined Inyx in June 2004.From November 2003 until joining Inyx, Mr. Bartke was a self-employed consultant to pharmaceutical companies.Prior to that, Mr. Bartke served as Vice President Global Sales & Marketing of PowderJect Pharmaceuticals Plc, where he directed sales growth from approximately $40 million to in excess of $290 million during his two-year tenure from 2001 to August 2003, at which time PowderJect was acquired and Mr. Bartke became a pharmaceutical industry consultant focusing on U.S. and European markets.Mr. Bartke began his professional career and served for 17 years, from 1984 to 2001, with GlaxoSmithKline ("GSK") in a number of different executive capacities.He started out in manufacturing management positions before moving into several marketing directorships at SmithKline Beecham Pharmaceuticals.In his last position with GSK, he served as Therapy Area Director, Vaccines, for GSK Pharmaceuticals Europe.Mr. Bartke holds a BSc in Pharmacy and a Ph.D. in Pharmaceutical Chemistry from the University of Berlin.


Ulrich Bartke Appointed to New Position of Vice President Global Sales & Marketing of Inyx

www.prnewswire.com [cached]

Ulrich Bartke Appointed to New Position of Vice President Global Sales & Marketing of Inyx - Will Direct Intensified Sales Growth and Strategic Marketing Initiatives -

NEW YORK, May 27 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), an emerging specialty pharmaceutical company with a focus on niche drug delivery technologies and products, announced today that Ulrich Bartke, Ph.D. will be joining the company on June 1, 2004 in the newly established, senior management position of Vice President Global Sales & Marketing.
...
"Initially, Mr. Bartke will focus on building Inyx's contract manufacturing revenues and increasing the utilization of production capacity, with the objective to increase sales and profitability," Dr. Kachkar informed.
...
"I am very pleased to be joining Inyx," said Mr. Bartke."Inyx has niche aerosol pharmaceutical development and production expertise that is needed in the marketplace today, particularly the proven ability to develop and produce non-ozone-depleting aerosol products.I am looking forward to assisting in the growth of Inyx's business."Mr. Bartke will be based initially at the company's development and production center located in Cheshire, England, operated under its wholly owned subsidiary INyX Pharma Limited.He will be directing the company's sales and marketing activities around the world, including in North America, Latin and South America and Asia as well as Europe.
Ulrich Bartke, Ph.D. From 2001 to 2003, Mr. Bartke served as Vice President Global Sales & Marketing of PowderJect Pharmaceuticals Plc, where he directed sales growth from approximately $40 million to in excess of $290 million during his two- year tenure.In June 2003, PowderJect, at the time a publicly owned company traded on the London Stock Exchange, was acquired by Chiron Corporation.Following this acquisition, Mr. Bartke became a consultant to the pharmaceutical industry, focusing on U.S. and European markets.Mr. Bartke began his professional career and served for 17 years, from 1984 to 2001, with GlaxoSmithKline companies in a number of different executive capacities.He started out in manufacturing management positions before moving into several marketing directorships at SmithKline Beecham Pharmaceuticals.In his last position, he served as Therapy Area Director, Vaccines, for GSK Pharmaceuticals Europe.Mr. Bartke holds a BSc in Pharmacy and a Ph.D. in Pharmaceutical Chemistry from the University of Berlin.


Cameron Associates

www.cameronassoc.com [cached]

ULRICH BARTKE APPOINTED TO NEW POSITION OF VICE PRESIDENT GLOBAL SALES & MARKETING OF INYX

...
Home < Client News and Info < Inyx, Inc. < Press Releases < ULRICH BARTKE APPOINTED TO NEW POSITION OF VICE PRESIDENT GLOBAL SALES & MARKETING OF INYX
...
ULRICH BARTKE APPOINTED TO NEW POSITION OF VICE PRESIDENT GLOBAL SALES & MARKETING OF INYXWill Direct Intensified Sales Growth and Strategic Marketing Initiatives
NEW YORK - May 26, 2004 - Inyx, Inc. (OTC BB: IYXI), an emerging specialty pharmaceutical company with a focus on niche drug delivery technologies and products, announced today that Ulrich Bartke, Ph.D. will be joining the company on June 1, 2004 in the newly established, senior management position of Vice President Global Sales & Marketing.
...
"Initially, Mr. Bartke will focus on building Inyx's contract manufacturing revenues and increasing the utilization of production capacity, with the objective to increase sales and profitability," Dr. Kachkar informed.
...
"I am very pleased to be joining Inyx," said Mr. Bartke."Inyx has niche aerosol pharmaceutical development and production expertise that is needed in the marketplace today, particularly the proven ability to develop and produce non-ozone-depleting aerosol products.I am looking forward to assisting in the growth of Inyx's business."
Mr. Bartke will be based initially at the company's development and production center located in Cheshire, England, operated under its wholly owned subsidiary INyX Pharma Limited.He will be directing the company's sales and marketing activities around the world, including in North America, Latin and South America and Asia as well as Europe.
Ulrich Bartke, Ph.D.
From 2001 to 2003, Mr. Bartke served as Vice President Global Sales & Marketing of PowderJect Pharmaceuticals Plc, where he directed sales growth from approximately $40 million to in excess of $290 million during his two-year tenure.In June 2003, PowderJect, at the time a publicly owned company traded on the London Stock Exchange, was acquired by Chiron Corporation (Nasdaq: CHIR).Following this acquisition, Mr. Bartke became a consultant to the pharmaceutical industry, focusing on U.S. and European markets.
Mr. Bartke began his professional career and served for 17 years, from 1984 to 2001, with GlaxoSmithKline (NYSE: GSK) companies in a number of different executive capacities.He started out in manufacturing management positions before moving into several marketing directorships at SmithKline Beecham Pharmaceuticals.In his last position, he served as Therapy Area Director, Vaccines, for GSK Pharmaceuticals Europe.
Mr. Bartke holds a BSc in Pharmacy and a Ph.D. in Pharmaceutical Chemistry from the University of Berlin.

Similar Profiles

Other People with this Name

Other people with the name Bartke

Di Bartke
Elmira Pet Products Ltd

Erin Bartke
The Crag

Andrzej Bartke
Southern Illinois University

Thomas Bartke
webinarjam

Ken Bartke

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory